Clonify was born in 2019 as a tool to improve high-cost medications ACCESS. It was part of an innovation project of the DMO design company. In January 2020 the product was ready to be launched, but the global pandemic challenged this, but at the same time helped us to re-evaluate our mission and thus transform ourselves from a digital solution to a digital health company.
¨We have the commitment and the opportunity to improve people's quality of life through technology...¨
Martin Ries Centeno CEO & Co-founder
The colors we see at every sunrise and sunset are the colors that mean life, it is the day by day and we want through technology to be able to "recharge" the possibility of improving the quality of life.
